Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BHCG Levels as Indicator for MTX Success in Ectopic Pregnancy
NCT01860690Phase 4Unknown
- Sponsor
- Meir Medical Center
- Start
- Nov 2011
- Primary completion
- Nov 2013
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of methotrexate in Ectopic pregnancy (EP), sponsored by Meir Medical Center. Primary endpoint: Change of levels of BHCG at Day 10. Status: unknown.
02
Drugs
methotrexate
03
Conditions
Ectopic pregnancy (EP)
Beyond the preview
Go deeper on NCT01860690.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01860690.